Already have an account?


Login with an existing Projects In Knowledge account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy
Education Initiative in Diabetes

  • Diabetes — Does SGLT-2 Inhibition Have a Role in the Management of Diabetes? – Webcast
  • As the incidence of type 2 diabetes mellitus continues to increase in both the United States and worldwide, the need for new options of effective treatment has become even greater. In meeting this challenge, several novel classes of antidiabetic agents have been developed and are now available. The most ... more >>
    V. Fonseca, MD, FRCP
  • Diabetes — Type 2 Diabetes Treatment: Novel Therapies GLP-1 Receptor Agonists/Analogs and DPP-4 Inhibitors – Webcast
  • Incretin-based therapies—GLP-1 receptor agonists and DPP-4 inhibitors—have a number of benefits compared with conventional therapies for type 2 diabetes mellitus (T2DM). Several new agents from this drug class have been approved in the past few years and are now in clinical practice. In this webcast, Jaime ... more >>
    J. Davidson, MD
  • Diabetes — Expert Insight Into: Efficacy and Safety of an SGLT-2 Inhibitor Versus a Sulfonylurea in Patients with Type 2 Diabetes Inadequately Controlled with Metformin: A Randomized, Double-Blind, Noninferiority 52-Week Trial (part 3 of Series) – Article Review
  • When blood glucose levels in type 2 diabetes are not adequately controlled with metformin monotherapy, a second oral agent is added. However, many agents increase body weight and/or increase the risk of hypoglycemia, which are particularly undesirable for patients with type 2 diabetes. Anne Peters, MD, ... more >>
    A. Peters, MD
  • Diabetes — Chapter 4.6: Investigational Therapies for T2DM: Other Emerging Options – @Point of Care Chapter
  • This subchapter of the type 2 diabetes mellitus (T2DM) learning platform addresses investigational therapies for the treatment of patients with T2DM, with a particular focus on novel insulin-based treatments, as well as alternatives to insulin regimens. New formulations and enhanced pharmacokinetics ( ... more >>
    A. Garber, MD, PhD, FACE
  • Diabetes — Chapter 4.7: Approved and Emerging Treatment Options for Type 1 Diabetes – @Point of Care Chapter
  • This subchapter reviews approved and emerging treatment options for type 1 diabetes. Throughout the subchapter, you will find supportive multimedia hyperlinks that provide access to videos, journal articles, glossary terms, and other resources to enhance understanding of relevant issues, including the ... more >>
    A. Garber, MD, PhD, FACE
  • Diabetes — Expert Insight Into: Dose-Dependent Effects of Monotherapy with a Once-Weekly GLP-1 Analog on Glycemic Control in Patients with T2DM (Part 3 of Series) – Article Review
  • In a constantly evolving treatment landscape, GLP-1 analogs are a relatively new option for patients with type 2 diabetes mellitus (T2DM). In this article review, Dr. Blonde discusses an emerging GLP-1 analog, dulaglutide. The results of the phase II study, detailed here, indicate that dulaglutide monotherapy ... more >>
    L. Blonde, MD, FACP, FACE
  • Diabetes — Expert Insight Into: 2-Year Efficacy and Safety of an SGLT-2 Inhibitor in Patients with Type 2 Diabetes Receiving High Doses of Insulin (Part 2 of Series) – Article Review
  • Even with a combination of diet and lifestyle therapy, oral glucose-lowering medications, and insulin therapy, a substantial proportion of type 2 diabetes patients fail to meet or maintain glycemic targets. As insulin therapy is escalated in these patients, insulin-associated weight gain, fluid retention and ... more >>
    C. Desouza, MD, MBBS
  • Diabetes — Case Study: The Role of SGLT-2 Inhibitors in the Management of Type 2 Diabetes Mellitus – Case Study
  • A patient-centered approach to improving glycemic control in patients with type 2 diabetes mellitus includes individualizing hemoglobin A1c targets as well as antihyperglycemic regimens. Clinicians can now choose from a new class of antihyperglycemics—sodium-glucose cotransporter 2 (SGLT-2) inhibitors—when ... more >>
    V. Fonseca, MD, FRCP
  • Diabetes — Long-Term Efficacy of an SGLT-2 Inhibitor in Patients with Type 2 Diabetes Mellitus Receiving High Doses of Insulin – Journal Insights
  • Type 2 diabetes mellitus patients with inadequately controlled diabetes despite substantial doses of insulin are particularly difficult to manage, as treatment options also increase risks for weight gain, hypoglycemia, fluid retention, and congestive heart failure. These effects in turn result in decreased ... more >>
    V. Fonseca, MD, FRCP
  • Diabetes — A Curriculum for the Management of T2DM Patients with SGLT-2 Inhibitors – Curriculum
  • The unprecedented increase in recently improved and emerging antidiabetic agents seen over the last few years has dramatically expanded the ability of clinicians to treat patients with type 2 diabetes. Among the newest of these agents are the sodium glucose cotransporter 2 (SGLT-2) inhibitors, a class of ... more >>
    V. Fonseca, MD, FRCP
  • A Curriculum for the Management of T2DM Patients with SGLT-2 Inhibitors
  • The unprecedented increase in recently improved and emerging antidiabetic agents seen over the last few years has dramatically expanded the ability of clinicians to treat patients with type 2 diabetes. Among the newest of these agents are the sodium glucose cotransporter 2 (SGLT-2) inhibitors, a class of ... more >>
    V. Fonseca, MD, FRCP
  • T2DM Tool Kit: Managing Patients with Incretin-Based Therapies
  • A Tool Kit for the Management of T2DM Patients with Incretin-Based Therapies is an online CME/CE program, chaired by Anne Peters, MD, that employs multiple educational formats to provide clinicians with tools and training to enhance the care of patients with type 2 diabetes mellitus (T2DM). Through a webcast, ... more >>
    A. Peters, MD
  • Type 1 Diabetes Mellitus: Tool Kit of Evidence-Based Strategies to Improve Care
  • Patients with type 1 diabetes mellitus (T1DM) require lifelong insulin therapy and glucose monitoring. Type 1 Diabetes Mellitus: Tool Kit of Evidence-Based Strategies to Improve Care will provide physicians and other healthcare professionals involved in the care of T1DM patients with up-to-date, practical ... more >>
    J. Davidson, MD
  • T2DM: Case-Based Video Vignettes
  • This point-of-care comprehensive video case library, chaired by John B. Buse, MD, PhD, explores common clinical challenges and best practices in the treatment and management of patients with type 2 diabetes mellitus (T2DM). Six case vignettes focus on real-world scenarios encountered in daily practice: how to ... more >>
    J. Buse, MD, PhD
  • Type 2 Diabetes Mellitus in Practice: Diabetes Curriculum II Program
  • Type 2 Diabetes Mellitus (T2DM) in Practice Curriculum II is a multi-format online program designed to help clinicians enhance their care of patients with T2DM. Featuring expert faculty chaired by Jaime Davidson, MD, this program will provide up-to-date information about current and emerging therapies and ... more >>
    J. Davidson, MD
  • Curriculum in: Type 2 Diabetes Mellitus in Practice
  • Type 2 Diabetes Mellitus in Practice, a multi-format online curriculum designed to help clinicians enhance their care of patients with T2DM, includes five webcasts, four podcasts, a five-chapter Living Medical Textbook, and MedPage Today meeting coverage.

    The webcasts and podcasts will cover such important ...
    more >>
    J. Davidson, MD
    A. Garber, MD, PhD, FACE
  • Diabetes @Point of Care
  • This web-based reference tool is designed for busy clinicians who want the latest information on new tools to manage type 1 and 2 diabetes mellitus (T2DM). With an emphasis on self-monitoring of blood glucose and novel therapies, this platform explores how best to help patients achieve treatment goals. ... more >>
    A. Garber, MD, PhD, FACE
    J. Green, MD
  • Diabetes — Case Study: The Role of SGLT-2 Inhibitors in the Management of Type 2 Diabetes Mellitus – Case Study
  • A patient-centered approach to improving glycemic control in patients with type 2 diabetes mellitus includes individualizing hemoglobin A1c targets as well as antihyperglycemic regimens. Clinicians can now choose from a new class of antihyperglycemics—sodium-glucose cotransporter 2 (SGLT-2) inhibitors—when ... more >>
    V. Fonseca, MD, FRCP
  • Diabetes — Case Study: Addressing Renal Impairment and Hypertension in Elderly Patients with T2DM – Case Study
  • The treatment of elderly patients with type 2 diabetes mellitus (T2DM) is often complicated by renal impairment and comorbidities, such as hypertension. This affects the choice of antihyperglycemic therapies and may necessitate additional treatments, such as antihypertensives. Join Anne L. Peters, MD, in this ... more >>
    A. Peters, MD
  • Diabetes — Case Study: Focus on Patient Transitioning from Pediatric to Adult Care – Tx Reporter e-Newsletter
  • The transition from adolescence into adulthood is a challenging time, particularly for patients with type 1 diabetes mellitus (T1DM). As young patients become independent and experience changes in their lives, clinicians need to help them stay on course with their diabetes care so that they may maintain ... more >>
    A. Peters, MD
  • Diabetes — Case-Based Video Vignette: Incretin-Based Therapies in T2DM Patients with Hypoglycemia – Video Case Vignette
  • Many patients with type 2 diabetes mellitus (T2DM) are concerned about hypoglycemia. When selecting therapies to achieve glycemic control in patients with T2DM, the risk of hypoglycemia should also be taken into account. In this case-based video vignette, Dr. Lawrence Blonde discusses the role of hypoglycemia ... more >>
    L. Blonde, MD, FACP, FACE
  • Diabetes — Case-Based Video Vignette: Incretin-Based Therapies in T2DM Patients with Renal Impairment – Video Case Vignette
  • Renal disease is a common long-term complication in patients with type 2 diabetes mellitus (T2DM). It affects the selection and dosing of therapies for T2DM, including incretin-based therapies, and may also have additional implications for patient management. In this case-based video vignette, Dr. Richard E. ... more >>
    R. Pratley, MD
  • Diabetes — Case-Based Video Vignette: Cardiovascular Disease in T2DM and Management Strategies – Video Case Vignette
  • Cardiovascular disease is a major cause of mortality in patients with type 2 diabetes mellitus (T2DM). Cardiovascular considerations need to be addressed in selecting optimal T2DM therapy. Antidiabetic treatments that are not associated with weight gain may play a role in the management of such patients. Join ... more >>
    R. DeFronzo, MD
  • Diabetes — Case-Based Video Vignette: Incretin-Based Therapies in the Elderly T2DM Patient Population – Video Case Vignette
  • Elderly patients with type 2 diabetes mellitus (T2DM) include patients who are otherwise healthy with no complications as well as patients who have cardiovascular disease, renal disease, or other comorbidities. Glycemic targets and treatment options for elderly patients with T2DM therefore need to be ... more >>
    A. Peters, MD
  • Diabetes — Case-Based Video Vignette: The Obesity Epidemic and T2DM – Video Case Vignette
  • Obesity is a problem for many patients with type 2 diabetes mellitus (T2DM), and patients may be concerned about additional weight gain with regard to treatment options. For some patients, newer incretin-based therapies that are not associated with weight gain may be appropriate. Dr. Steven R. Smith discusses ... more >>
    S. Smith, MD
  • Diabetes — Case-Based Video Vignette: Translating New T2DM Guidelines into Practice – Video Case Vignette
  • The management of patients with type 2 diabetes mellitus (T2DM) should take into consideration patient factors such as disease state and comorbidities as well as financial resources and motivation. This approach is outlined in new guidelines issued by the American Diabetes Association (ADA) and the European ... more >>
    V. Fonseca, MD, FRCP
  • Diabetes — Case Study: Approaches to Treatment in Patients with Type 2 Diabetes at Risk for Hypoglycemia – Tx Reporter e-Newsletter
  • Hypoglycemia is the primary treatment-limiting factor in type 2 diabetes mellitus. Elderly patients and patients taking sulfonylureas or insulin treatment are among those at risk. In this TxReporter, Zachary Bloomgarden, MD, describes the case of an 84-year-old man whose diabetes is not adequately controlled ... more >>
    Z. Bloomgarden, MD